Navigation Links
Celator(R) Pharmaceuticals to Present at 2008 BIO International Convention
Date:6/16/2008

PRINCETON, N.J., June 16 /PRNewswire/ -- Celator Pharmaceuticals today announced that John Bennett, head of business development, is scheduled to present at the BIO Business Forum during the Biotechnology Industry Organization (BIO) International Convention in San Diego. Mr. Bennett will provide a corporate overview and an update on Celator's clinical development programs. The presentation will be held on Wednesday, June 18, 2008 at 3:30 PDT in Room 3 of the San Diego Convention Center.

About Celator

Celator Pharmaceuticals, Inc., is a privately held pharmaceutical company working to develop new and more effective therapies to treat cancer. CombiPlex(TM), the company's drug ratio technology platform, represents a revolutionary new approach to the development of combination therapies based on identifying a fixed, synergistic ratio of the drugs pre-clinically, incorporating that ratio in a drug delivery vehicle and maintaining the ratio in patients. The company pipeline includes: CPX-1 (a liposomal formulation of irinotecan:floxuridine), currently in a Phase 2 trial in patients with colorectal cancer; CPX-351 (a liposomal formulation of cytarabine:daunorubicin), currently in a Phase 1 trial in patients with leukemia; CPX 571 (a liposomal formulation of irinotecan:cisplatin), a preclinical stage compound; and multiple research programs. Based on the applications of CombiPlex, Celator is positioned to advance a broad pipeline of combination therapies involving both previously approved and novel drug agents. For more information, please visit the company's website at http://www.celatorpharma.com.


'/>"/>
SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Celator(R) Pharmaceuticals Announces Appointment of Scott Jackson as CEO
2. Celator(R) Pharmaceuticals to Present at 10th Annual BIO CEO and Investor Conference
3. Celator(R) Pharmaceuticals Study Shows CPX-571 Maintains Synergistic Ratio of Irinotecan and Cisplatin to Improve Anti-tumor Activity
4. Scimitar Equity, LLC Initiates Coverage Review of VioQuest Pharmaceuticals, Inc.
5. GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections
6. Raptor Pharmaceuticals Corp. To Present at BIO 2008 International Convention
7. Jazz Pharmaceuticals Files Form S-3 Registration Statements
8. Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference
9. Merrimack Pharmaceuticals Raises $60 Million in Private Financing
10. The Leukemia & Lymphoma Society and Provid Pharmaceuticals Announce Collaboration on Treatment for Acute Myelogenous Leukemia
11. Diffusion Pharmaceuticals Announces Addition of Mark T. Giles to its Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009).... 1 Prairie Heart Institute of Ill...ently awarded two statuettes at the first-ever CLI...ity. The CLIO Healthcare Awards recognizes creativ...rtising industry and is an extension of the CLIO A...ompetitions for advertising, design and interactiv...
(Date:12/1/2009)...level storage is now available to small and medium...bank. , (PRWEB) December ..., a medical imaging software company, announced th...service. The PacsDrive service enables small and m...ive medical imaging in compliance with HIPAA regul...
(Date:12/1/2009)...oftware agrees to migrate their Microsoft Dynamics... to Synergy Business Solutions to maintain quality...PRWEB) December 1, 2009 -- Synergy Business Soluti...Dynamics SL practice of Congruent Software, a Bell...s necessary due to a change in Congruent Software&...
(Date:12/1/2009)...1 Aethlon Medical, Inc. ... will present at the LD MICRO Conference on Thursd...e Hotel in Los Angeles. Aethlon Medical,s Chairman... overview and will provide an update on the compan...mopurifier®, a first-in-class artificial adju...
Breaking Biology Technology:Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2
...anned for June 2009 in New York City, WASHINGTON,...s, Demy-Colton Life Science Advisors, the EBD Grou...Partnering for Philanthropy, a new,partnering meet...cal,research and patient advocacy groups, and to f...harmaceutical companies. The inaugural meeting wil...
...l Present on the Strategic Value of Literature Mod...ibutes in Clinical Development, MOUNTAIN VIEW, Ca...T ), a leading provider of software, strategic,con...inical drug,development, today announced that Fark...gic Consulting Services, has been invited to speak...
...nology Identifies DNA Variations Between a Referen... OMAHA, Neb., June 17 Transgenomic (OTC,Bulletin...g SURVEYOR,Endonuclease Adaptor-ligated Libraries ...ing technology for whole genome analysis, SEAL ide...and a test genome. SEAL is,designed to recognize p...
Other Biology Technology:Partnering for Philanthropy Conference Launched to Unite Innovative Non-profit Research Organizations with Philanthropists and Industry 2Partnering for Philanthropy Conference Launched to Unite Innovative Non-profit Research Organizations with Philanthropists and Industry 3Pharsight to Present on Literature-Based Disease Modeling Approaches at AAPS National Biotechnology Conference 2Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation 2Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation 3Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation 4
(Date:12/1/2009)...io Ohio State University cancer researchers have ... brain-tumor cells and blocks the growth of new tu...iruses designed to kill cancer cells oncolytic vi...brain tumors if they also carry a gene for a prote...in, called vasculostatin, is normally produced in ...
(Date:12/1/2009)...-Ari, winner of the 2009 Inserm Grand Prix., Eve...ment to paying tribute to outstanding,work perfor...ing talents, Inserm intends to,demonstrate the di...,s biological, medical and,health research, and t... carry out and,drive this research each day. The ...
(Date:12/1/2009)... Fla. Hit-and-run attacks by sharks can be solved... by the unique chomp they put on their victims, ac...shark expert. , In a method analogous to analyzi...ications by precisely comparing shark bites to the...orge Burgess, director of the International Shark ...
Breaking Biology News(10 mins):Tumor-attacking virus strikes with 'one-two punch' 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3NIH announces 115 awards to encourage high risk research and innovation 10088 1NIH announces 115 awards to encourage high risk research and innovation 10088 2American Society Of Plastic Surgeons Hosts 78th Annual Meeting 58270 1American Society Of Plastic Surgeons Hosts 78th Annual Meeting 58270 2American Society Of Plastic Surgeons Hosts 78th Annual Meeting 58270 3American Society Of Plastic Surgeons Hosts 78th Annual Meeting 58270 4Increased Demand for Training Leads to Expansion in Alberta 58266 1Increased Demand for Training Leads to Expansion in Alberta 58266 2
...stroke has taken a major step forward following pr...esearchers at The University of Manchester have sh...ng protein called IL-1ra protects brain cells from...ancy Rothwell and Dr Pippa Tyrrell, have now repor... in patients, which are published in the Journal o...
...chers have demonstrated how the microenvironments ...erally approved) induced metastatic melanoma cells...he ability to form colonies similar to hESCs. The ...were less invasive following culture on the microe...t the potential utility of isolating the factors w...
...tated South Asian communities, global fisheries ex...ation programs are much needed to revive severely ...sustainable livelihoods than fishing. , According ...ntre (see ? Rebuilding Boats May Not Equal Rebuild...n Tsunami-Affected Coastal Communities in Asia, at...
Other Biology News:Stroke treatment a step closer after trial 2Stem cell microenvironment reverses malignant melanoma 2Tsunami + 1 year: Reviving exhausted fisheries should trump replacing boats, gear, experts say 2Tsunami + 1 year: Reviving exhausted fisheries should trump replacing boats, gear, experts say 3Tsunami + 1 year: Reviving exhausted fisheries should trump replacing boats, gear, experts say 4
Porcine TNF-alpha (TNFSF1A) ELISA development Kit, DuoSet Economy Pack from R&D Systems
...[14C] Methylated Protein Molecular Weight Markers,...teins enable molecular weight determination of the...on also allows visual monitoring of band migration...of the [14C] version without Rainbow-labeling is 0...
Streptavidin, Fluorescein conjugated/tagged from R&D Systems
Zero Blunt TOPO PCR Cloning Kit for Sequencing with One Shot TOP10 Electrocomp E. coli from Invitrogen
Biology Products: